key: cord-1049320-wbki1ly8
authors: Dash, Girish Chandra; Rout, Usha Kiran; Nanda, Rashmi Ranjan; Parai, Debaprasad; Choudhary, Hari Ram; Kanungo, Srikanta; Palo, Subrata Kumar; Kshatri, Jaya Singh; Turuk, Jyotirmayee; Mishra, Bijaya Kumar; Pati, Sanghamitra; Bhattacharya, Debdutta
title: Pooled testing for SARS‐CoV‐2 infection in an automated high‐throughput platform
date: 2021-06-28
journal: J Clin Lab Anal
DOI: 10.1002/jcla.23835
sha: 504def7e6390cbf919e7f6a5332e7ac3667ee66d
doc_id: 1049320
cord_uid: wbki1ly8

BACKGROUND: Active detection of SARS‐CoV‐2 infection through testing is elementary for the control of COVID‐19 pandemic. The implementation of large‐scale RT‐PCR testing has led to a rise in the demand for testing kits whose availability is always a concern. OBJECTIVE: To find out the feasibility of pooled testing in a high‐throughput platform. METHODOLOGY: Pooled testing was conducted in Roche cobas 6800 in 2 methods. Firstly, the simple two‐stage testing algorithm was conducted for 1410 samples individually and then as pooled samples. Secondly, we evaluated the sensitivity of cobas 6800 for the detection of a single positive sample within a pool of negative samples. RESULTS: Implementing the five‐sample Dorfman pooling to test 1410 samples, we identified 42 (2.9%) individual SARS‐CoV‐2‐positive samples and 27 (9.5%) positive pool samples. The pooling strategy precisely identified all the positive samples. All individually negative samples were also accurately determined by pooling. There was 100% sensitivity of detecting positive samples in a pool of negative samples even up to 1:64 dilution. There was a threefold increase in total throughput in one‐third of the cost per day. CONCLUSION: A high‐throughput platform such as Cobas 6800 can effectively increase the testing capacity by twofold to threefold by adopting the pooled testing strategy for successful management of SARS‐CoV‐2 and helping in the containment of community transmission.

COVID-19 pandemic since its detection in December 2019 has raised a major concern and challenge for healthcare services and their infrastructure. 1,2 RT-PCR-based diagnostic confirmation of infected individuals is considered to be crucial to contain viral spread because the infection can be asymptomatic despite high viral loads. 3 It has spread rapidly to both developed and developing countries, with most countries facing acute scarcity of certain reagents that are critical for performing SARS-CoV-2 detection assays. 4 There is uncertainty regarding patterns, reinfection, and vaccination of COVID-19, which has led to an enormous demand for testing worldwide, especially in a heavily populated country such as India. 5 Detection of new strains of SARS-CoV-2 has again stressed the timely and accurate testing for early detection and treatment or prevention of COVID-19 infection in the community. 6 India is currently 2 nd most affected country with more than 10 million cases with a testing capacity of around 1 million tests per day. 7, 8 In view of this, we carried out a study to understand the feasibility of pooling in the high-throughput platform and to propose a testing strategy that is simple to enforce and can extend the capacity of the existing laboratory facilities and test kits when screening a large number of individuals.

All the samples were collected from different parts of Odisha, India, and tested at ICMR-Regional Medical Research Centre, Bhubaneswar, using Cobas 6800 instrument. The instrument targets two genes, that is, the ORF1 gene, which is a non-structural region that is unique to SARS-CoV-2 (target 1); and the E gene, which is a conserved region in the structural protein envelope for pan-sarbecovirus detection 

The mean age of the samples tested was 32.29 (± 15.34) years, ranging from 6 to 78 years. The male population (68.4%) was found to be significantly higher than the female population (31.6%). The samples tested were predominantly collected from asymptomatic individuals Table 2 ). The cycle threshold (Ct) values were found to be in increasing order as the dilution level increases for both the targeted genes. 11 In our study, we undertook a maximum calculation of 10-pool strategy as the positivity rate was high. Our study showed there is an increase in productivity until 20% positivity rate after which there is a decline in the maximum number of samples tested per day. Various studies have suggested 30-pool strategy in low prevalence areas. 12 Our study showed that Cobas 6800 can effectively detect the positive sample in a dilution of 1:64 samples, which was the first of its kind to find out the sensitivity of Cobas 6800. 

Sanghamitra Pati

COVID-19-new insights on a rapidly changing epidemic

Diagnostic testing for the novel coronavirus

Pooling of samples for testing for SARS-CoV-2 in asymptomatic people

Assessment of specimen pooling to conserve SARS CoV-2 testing resources

pathogenesis, diagnosis and in-line treatment of COVID-19

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Home | Ministry of Health and Family Welfare | GOI [Internet].|Home | Ministry of Health and Family Welfare | GOI

The detection of defective members of large populations

Pooling of nasopharyngeal swab specimens for SARS-CoV-2 detection by RT-PCR

Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection

Effectiveness of sample pooling strategies for SARS-CoV-2 mass screening by RT-PCR: a scoping review

Pooled testing for expanding COVID-19 mass surveillance

Pooling samples to increase SARS-CoV-2 testing